32 results on '"Meredith, P.A."'
Search Results
2. Drug safety
3. Nifedipine GITS
4. Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk
5. G-006 CARDIOVASCULAR OUTCOMES IN HYPERTENSIVES TREATED EXCLUSIVELY WITH NIFEDIPINE GITS OR CO-AMILOZIDE
6. G-015 PROGNOSTIC VALUE OF BLOOD PRESSURE AND “EARLY” BLOOD PRESSURE CONTROL IN PATIENTS WITH CORONARY ARTERY DISEASE
7. G-003 BENEFITS OF NIFEDIPINE GITS IN STABLE CORONARY ARTERY DISEASE
8. Benefits of nifedipine GITS in stable coronary artery disease: further analysis of the “ACTION” database
9. Efficacy of low-density-lipoprotein lowering with statins
10. Antihypertensive drugs: Individualized analysis and clinical relevance of kinetic-dynamic relationships
11. Assessment of the PKU card as a retrospective index of neonatal blood lead status
12. Delta-aminolaevulinic acid metabolism in normal and lead-exposed humans
13. The percutaneous absorption of lead-203 in humans from cosmetic preparations containing lead acetate, as assessed by whole-body counting and other techniques
14. Effects of Aluminium, Lead and Zinc on δ-Aminolaevulinic Acid Dehydratase
15. Concentration Effect Analysis of the Prazosin Derivatives, Trimazosin and Doxazosin
16. HEPATIC DRUG METABOLISM AND HAEM BIOSYNTHESIS IN LEAD-POISONED RATS
17. The Pharmacokinetics and Pharmacodynamics of Verapamil in Elderly Hypertensives
18. Acute and Chronic Nifedipine in Essential Hypertension: Concentration-Effect Relationships
19. Steady state PK of doxazosin GITS versus doxazosin standard and the potential benefits of GITS in the treatment of hypertensive patients
20. Outcome differences between ACE inhibitor and calcium channel blocker treated hypertensives
21. ACE inhibitors and outcome in treated hypertensive patients
22. A031: ACE inhibitors and outcome in treated hypertensive patients.
23. A032: Outcome differences between ACE inhibitor and calcium channel blocker treated hypertensives.
24. A062: Steady state PK of doxazosin GITS versus doxazosin standard and the potential benefits of GITS in the treatment of hypertensive patients.
25. An assessment of the pharmacokinetics and pharmacodynamics of single doses of amlodipine in elderly normotensives
26. The influence of age on the pharmacokinetics of verapamil
27. The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection
28. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection
29. DO ace inhibitors protect against cancer?
30. Cancer risk in hypertensive patients treated with calcium channel blockers.
31. Do ace inhibitors reduce mortality in hypertensive patients?
32. The physiologically realistic characterisation of benazeprilat pharmacokinetics in young and elderly volunteers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.